Human nephrotoxicity prediction models for three types of kidney injury based on data sets of pharmacological compounds and their metabolites

Sehan Lee, Young Mook Kang, Hyejin Park, Mi Sook Dong, Jae Min Shin, Kyoung Tai No

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The kidney is the most important organ for the excretion of pharmaceuticals and their metabolites. Among the complex structures of the kidney, the proximal tubule and renal interstitium are major targets of nephrotoxins. Despite its importance, there are only a few in silico models for predicting human nephrotoxicity for drug candidates. Here, we present quantitative structure-activity relationship (QSAR) models for three common patterns of drug-induced kidney injury, i.e., tubular necrosis, interstitial nephritis, and tubulo-interstitial nephritis. A support vector machine (SVM) was used to build the binary classification models of nephrotoxin versus non-nephrotoxin with eight fingerprint descriptors. To build the models, we constructed two types of data sets, i.e., parent compounds of pharmaceuticals (251 nephrotoxins and 387 non-nephrotoxins) and their major urinary metabolites (307 nephrotoxins and 233 non-nephrotoxins). Information on the nephrotoxicity of the pharmaceuticals was taken from clinical trial and postmarketing safety data. Though the mechanisms of nephrotoxicity are very complex, by using the metabolite information, the predictive accuracies of the best models for each type of kidney injury were better than 83% for external validation sets. Software to predict nephrotoxicity is freely available from our Web site at http://bmdrc.org/DemoDownload.

Original languageEnglish
Pages (from-to)1652-1659
Number of pages8
JournalChemical Research in Toxicology
Volume26
Issue number11
DOIs
Publication statusPublished - 2013 Nov 18

All Science Journal Classification (ASJC) codes

  • Toxicology

Fingerprint Dive into the research topics of 'Human nephrotoxicity prediction models for three types of kidney injury based on data sets of pharmacological compounds and their metabolites'. Together they form a unique fingerprint.

  • Cite this